BioNTech Announces Breakthrough in mRNA Cancer Vaccine in Phase 2 Study
(BioNTech) BioNTech SE has treated the first colorectal cancer patient using the individualized vaccine BNT122 in a phase 2 trial. BioNTech has already initiated trials in the US, Spain, Germany,…